Bausch Health Companies | Rentekostnader



Interest Expense On Debt Endring Dato
Amgen USD 747M 29M 2024-12
ANI Pharmaceuticals USD 2.33M 2.33M 2024-09
Aurora Cannabis CAD 1.29M 768K 2024-12
Bausch Health Companies USD 346M 4M 2024-09
Biogen USD 60M 200K 2024-12
Bristol-Myers Squibb USD 496M 9M 2024-12
Canopy Growth CAD 16.77M 4.51M 2024-12
Corcept Therapeutics 6M 6M 2024-06
Danaher USD 61M 26M 2024-12
Drreddys Laboratories INR 817M 60M 2024-12
Eli Lilly USD 224.7M 78.4M 2024-12
Gilead Sciences USD 248M 10M 2024-12
Novo Nordisk 562M 40M 2024-09
Pacira USD 4.68M 9K 2024-12
Perrigo 43.1M 200K 2024-12
Prestige Brands USD 11.37M 908K 2024-12
Supernus Pharmaceuticals USD 0 0 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12
Zoetis USD 51M 6M 2024-12



Bausch Health Companies Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.